Adam Smith sold Weyerhaeuser Company (NYSE: WY)
Adam Smith (D-WA), a U.S. Representative, has disclosed 1 trade in Weyerhaeuser Company (WY) since 2025, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Adam Smith sold $1,001 - $15,000 of Weyerhaeuser Company (NYSE: WY) on August 8, 2025. Since that trade, WY is down -5.32% against the S&P 500 up +17.39%, an outperformance of -22.71%.
Data updated
Adam Smith's WY trades vs the price
WY is down -5.32% since Adam Smith sold on August 8, 2025, versus +17.39% for the S&P 500.
Performance since this trade
All Adam Smith WY trades
Adam Smith & WY trading FAQ
Is it legal for Adam Smith to trade Weyerhaeuser Company (WY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Weyerhaeuser Company (WY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Adam Smith sell WY?
Adam Smith disclosed a sale of $1,001 - $15,000 of Weyerhaeuser Company (WY) on August 8, 2025, according to public STOCK Act filings.
How has WY performed since Adam Smith's trade?
Since Adam Smith sold WY on August 8, 2025, the stock is down -5.32%, versus +17.39% for the S&P 500 over the same period, an outperformance of -22.71%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional WY trades?
Quantellect tracks every disclosed congressional trade in Weyerhaeuser Company (WY) on the Weyerhaeuser Company congressional trading page, which aggregates filings across all members of Congress.
Adam Smith's WY tradesAll congressional filings for Weyerhaeuser CompanyAdam Smith's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.